Winrevair

Sundry Photography Merck (NYSE:MRK) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its lung disease therapy Winrevair in combination with other medications for certain adults with pulmonary arterial hypertension (PAH). EMA’s Committee for Medicinal Products for Human Use (CHMP) issued aContinue Reading